About Careers MedBlog Contact us

Apomorphine: New Drug to Treat Parkinsonís Disease Introduced in India

by Adeline Dorcas on December 10, 2018 at 2:54 PM
Font : A-A+

Apomorphine: New Drug to Treat Parkinsonís Disease Introduced in India

New drug Apomorphine to treat Parkinson's disease is now available in a Bengaluru hospital.

A private hospital in Bengaluru in a tie-up with Britannia Pharmaceuticals, a UK-based pharmaceutical company, has jointly launched Apomorphine for the first time in India.


The drug has improved Parkinson's disease treatment in other countries and now offers new hope for Indians suffering from the disease.

Apomorphine drug is available both as injections and infusion pumps, which can provide quick relief to the Parkinson patients in a few minutes.

It is a potent stimulant for the brain to produce more dopamine. This provides Parkinson's patients a fast relief from symptoms and improves their quality of life, said the hospital.

Currently, in India, patients with Parkinson's disease have only two choices either oral treatment for the initial stages of the disease or very expensive Deep Brain Stimulation (DBS) surgery for advanced stages, said Dr. Prashant LK, Parkinson's Disease and Movement Disorders Specialist at Vikram Hospital.

Further, he added that there was no specific treatment for the middle stages of the disease. Moreover, most Indian patients could not afford DBS.

The drug will be distributed in the country by Vikram Hospitals and later made available in selected centers across the country after the approval of the Drug Controller General of India.

Source: Medindia

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Apomorphine: New Drug to Treat Parkinsonís Disease Introduced in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests